How much funding has Elephas Biosciences raised?

Elephas Biosciences has raised $136.5M in total funding, most recently a Extension Round.

Who are Elephas Biosciences's investors?

Elephas Biosciences's investors include Northpond Ventures, ARCH Venture Partners, State of Wisconsin Investment Board, IQ Capital, Venture Investors, Moore Strategic Ventures.

When was Elephas Biosciences founded?

Elephas Biosciences was founded in 2020.

Where is Elephas Biosciences headquartered?

Elephas Biosciences is headquartered in Madison, Wisconsin, United States.

What industry is Elephas Biosciences in?

Elephas Biosciences operates in Biotech, Oncology, Precision Medicine.

How many employees does Elephas Biosciences have?

Elephas Biosciences has 51-200 employees.

Elephas Biosciences

Home | Elephas | Elephas Platform

Madison, United States · Founded 2020 · $136.5M raised

Biotech

Oncology

Precision Medicine

Headquarters: Madison, Wisconsin
Employees: 51–200
Founded: 2020
Business Model: B2B

Website: elephas.com
Total Funding: $136.5M
Last Round: $40.0M Extension RoundNov 2025
Rounds: 5

About

Elephas Biosciences is a privately held precision oncology company based in Madison, Wisconsin, developing the elive™ platform — an ex vivo system that profiles live tumor biopsies to predict immunotherapy response. Founded in 2020, the company preserves native tumor microenvironments from core needle biopsies to enable real-time immune characterization, helping pharmaceutical and clinical partners improve cancer treatment selection.

Summary

Elephas Biosciences is a Biotech company based in Madison, United States, founded in 2020. It has raised $136.5M in total across 5 rounds, most recently a $40.0M Extension Round round in Nov 2025. Investors include Northpond Ventures, ARCH Venture Partners and State of Wisconsin Investment Board.